Dr. Jinming Yu, MD
Claim this profileShandong Cancer Hospital and Institute
Studies Non-Small Cell Lung Cancer
Studies Lung Cancer
9 reported clinical trials
20 drugs studied
Area of expertise
1Non-Small Cell Lung Cancer
Stage III
Stage IV
ALK negative
2Lung Cancer
Stage III
Stage IV
ALK negative
Clinical Trials Jinming Yu, MD is currently running
HB0036
for Advanced Cancer
This trial is testing a new drug called HB0036 in patients with advanced solid tumors, including NSCLC. The goal is to determine if the drug is safe and effective in treating these cancers.
Recruiting1 award Phase 1 & 211 criteria
Immunotherapy Combo
for Lung Cancer
This is a Phase III, randomised, double-blind, placebo-controlled, multicentre, international study assessing the efficacy and safety of durvalumab (MEDI4736) and domvanalimab (AB154) compared with durvalumab plus placebo in adults with locally advanced (Stage III), unresectable NSCLC whose disease has not progressed following definitive platinum-based cCRT.
Recruiting1 award Phase 310 criteria
More about Jinming Yu, MD
Clinical Trial Related3 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Jinming Yu, MD has experience with
- Carboplatin/Cisplatin-Etoposide
- HLX10
- Prophylactic Cranial Irradiation (PCI)
- Thoracic Radiotherapy
- Domvanalimab
- Durvalumab
Breakdown of trials Jinming Yu, MD has run
Non-Small Cell Lung Cancer
Lung Cancer
Cancer
Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jinming Yu, MD specialize in?
Jinming Yu, MD focuses on Non-Small Cell Lung Cancer and Lung Cancer. In particular, much of their work with Non-Small Cell Lung Cancer has involved Stage III patients, or patients who are Stage IV.
Is Jinming Yu, MD currently recruiting for clinical trials?
Yes, Jinming Yu, MD is currently recruiting for 4 clinical trials in Jinan Shandong. If you're interested in participating, you should apply.
Are there any treatments that Jinming Yu, MD has studied deeply?
Yes, Jinming Yu, MD has studied treatments such as Carboplatin/Cisplatin-Etoposide, HLX10, Prophylactic Cranial Irradiation (PCI).
What is the best way to schedule an appointment with Jinming Yu, MD?
Apply for one of the trials that Jinming Yu, MD is conducting.
What is the office address of Jinming Yu, MD?
The office of Jinming Yu, MD is located at: Shandong Cancer Hospital and Institute, Jinan, Shandong 250117 China. This is the address for their practice at the Shandong Cancer Hospital and Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.